Journal of pharmaceutical and biomedical analysis

Measuring iboga alkaloid levels in rat brains in real time using a fast chemical analysis method

Updated

Abstract

The developed UPLC-MS/MS method achieved lower limits of quantification of 0.78-1.56 ng/mL for various iboga alkaloids in rat brain microdialysate.

  • This method quantifies ibogaine, noribogaine, ibogamine, and oxa-noribogaine directly in brain extracellular fluid, unlike existing tissue homogenate approaches.
  • Calibration curves were linear for ibogamine (0.78-75 ng/mL) and for ibogaine, noribogaine, and oxa-noribogaine (1.56-75 ng/mL).
  • Intra- and inter-day accuracy and precision of all analytes met established acceptance criteria.
  • An isotopically labeled internal standard, D2-noribogaine, was used to enhance measurement sensitivity.
  • Noribogaine levels measured in the nucleus accumbens after a 10 mg/kg intraperitoneal dose reached a peak unbound extracellular fluid concentration of 292 ± 68 ng/mL at 50 minutes.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests. Dalibor Sames reports financial support was provided by National Institute of Drug Abuse. John M. Rimoldi reports financial support was provided by National Institute of General Medical Sciences. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free